Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q193978> ?p ?o }
Showing triples 1 to 58 of
58
with 100 triples per page.
- Q193978 subject Q7483856.
- Q193978 abstract "Cinacalcet (INN) is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues (Van Wagenen et al. (2001), U.S. Pat. 6,211,244). It is sold by Amgen under the trade name Sensipar in North America and Australia and as Mimpara in Europe. Cinacalcet is used to treat secondary hyperparathyroidism (elevated parathyroid hormone levels), a consequence of end-stage renal disease. Cinacalcet is also indicated for the treatment of hypercalcemia in patients with parathyroid carcinoma. Cinacalcet was FDA approved in March 2004, and was the first allosteric G protein-coupled receptor modulator to enter the pharmaceutical market. In 2014, cinacalcet was 76th out of the top 100 drugs in the list of largest selling pharmaceutical products.".
- Q193978 atcPrefix "H05".
- Q193978 atcSuffix "BX01".
- Q193978 bioavailability "20.0".
- Q193978 casNumber "226256-56-0".
- Q193978 chEBI "48390".
- Q193978 drugbank "DB01012".
- Q193978 fdaUniiCode "UAZ6V7728S".
- Q193978 iupacName "(R)-N-[1-(1-naphthyl)ethyl]-3-".
- Q193978 iupacName "[3-(trifluoromethyl)phenyl]propan-1-amine".
- Q193978 pubchem "156419".
- Q193978 thumbnail Cinacalcet_Structural_Formulae.png?width=300.
- Q193978 wikiPageExternalLink 0,3915,8207%7CCinacalcet,00.html.
- Q193978 wikiPageExternalLink a605004.html.
- Q193978 wikiPageExternalLink www.sensipar.com.
- Q193978 wikiPageExternalLink sensipar_pi.pdf.
- Q193978 wikiPageWikiLink Q12140.
- Q193978 wikiPageWikiLink Q1344835.
- Q193978 wikiPageWikiLink Q14860476.
- Q193978 wikiPageWikiLink Q14864419.
- Q193978 wikiPageWikiLink Q14864427.
- Q193978 wikiPageWikiLink Q14890102.
- Q193978 wikiPageWikiLink Q15321271.
- Q193978 wikiPageWikiLink Q2919083.
- Q193978 wikiPageWikiLink Q3622611.
- Q193978 wikiPageWikiLink Q40301.
- Q193978 wikiPageWikiLink Q40397.
- Q193978 wikiPageWikiLink Q470517.
- Q193978 wikiPageWikiLink Q5018775.
- Q193978 wikiPageWikiLink Q60097.
- Q193978 wikiPageWikiLink Q6625041.
- Q193978 wikiPageWikiLink Q7136153.
- Q193978 wikiPageWikiLink Q7483856.
- Q193978 wikiPageWikiLink Q824258.
- Q193978 wikiPageWikiLink Q845326.
- Q193978 wikiPageWikiLink Q936382.
- Q193978 wikiPageWikiLink Q9368.
- Q193978 wikiPageWikiLink Q9377.
- Q193978 atcPrefix "H05".
- Q193978 atcSuffix "BX01".
- Q193978 bioavailability "20".
- Q193978 bioavailability "Increases if taken with food".
- Q193978 casNumber "226256".
- Q193978 chebi "48390".
- Q193978 drugbank "DB01012".
- Q193978 iupacName "-N-[1-ethyl]-3-".
- Q193978 iupacName "[3-phenyl]propan-1-amine".
- Q193978 pubchem "156419".
- Q193978 unii "UAZ6V7728S".
- Q193978 type ChemicalSubstance.
- Q193978 type Drug.
- Q193978 type ChemicalObject.
- Q193978 type Thing.
- Q193978 type Q8386.
- Q193978 comment "Cinacalcet (INN) is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues (Van Wagenen et al. (2001), U.S. Pat. 6,211,244). It is sold by Amgen under the trade name Sensipar in North America and Australia and as Mimpara in Europe.".
- Q193978 label "Cinacalcet".
- Q193978 depiction Cinacalcet_Structural_Formulae.png.